Maritza Lienlaf

Biochemistry, Genetics and Molecular Biology · Life Sciences

11h-index1.1kcitations28works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Histone Deacetylase Inhibitors Research(22), Protein Degradation and Inhibitors(12), Peptidase Inhibition and Analysis(10), HIV Research and Treatment(4), Epigenetics and DNA Methylation(3)

Publications28 total

Expression of Concern: A Novel Role for Histone Deacetylase 6 in the Regulation of the Tolerogenic STAT3/IL-10 Pathway in APCs
The Journal of Immunology·2024
Essential role for histone deacetylase 11 (HDAC11) in neutrophil biology
Journal of Leukocyte Biology·2017· 61 citedOpen Access
Abstract 2331: HDAC6, new role as master regulator of PD-L1 and immune-related pathways
Cancer Research·2016· 1 cited
Essential role of HDAC6 in the regulation of PD‐L1 in melanoma
Molecular Oncology·2016· 164 citedOpen Access
Erratum to: Functional Analysis of Histone Deacetylase 11 (HDAC11)
Methods in molecular biology·2016· 1 cited
Functional Analysis of Histone Deacetylase 11 (HDAC11)
Methods in molecular biology·2016· 10 citedOpen Access
Expression and Function of Histone Deacetylase 10 (HDAC10) in B Cell Malignancies
Methods in molecular biology·2016· 11 cited
Targeting histone deacetylase 6 mediates a dual anti‐melanoma effect: Enhanced antitumor immunity and impaired cell proliferation
Molecular Oncology·2015· 134 citedOpen Access
Selective Inhibition of HDAC6 Decreases Viability of Cutaneous T-Cell Lymphoma and Improves Immune Recognition
Blood·2014
A Phase I/II Trial Evaluating the Use of a Histone Deacetylase Inhibitor Panobinostat (LBH589) in Addition to Glucocorticoids in Patients with Acute Graft-Versus-Host Disease
Blood·2014· 3 cited
Abstract 4089: Histone deacetylase 6 (HDAC6) as a regulator of PD-L1 expression through STAT3 modulation in melanoma
Cancer Research·2014· 1 cited
Abstract 4086: Histone deacetylase 6 (HDAC6) as a new target modulating the proliferation and immune-related pathways in melanoma
Cancer Research·2014
A Novel Role for Histone Deacetylase 6 in the Regulation of the Tolerogenic STAT3/IL-10 Pathway in APCs
The Journal of Immunology·2014· 105 citedOpen Access
Divergent roles of histone deacetylase 6 (HDAC6) and histone deacetylase 11 (HDAC11) on the transcriptional regulation of IL10 in antigen presenting cells
Molecular Immunology·2014· 137 citedOpen Access
Role Of Histone Deacetylase 6 (HDAC6) In The Modulation Of STAT Pathways and Immune Function Of APCs
Blood·2013· 1 cited
The antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicity
Melanoma Research·2013· 100 citedOpen Access
Abstract 5246: Histone deacetylase 6 (HDAC6) as a new modulator of the JAK/STAT pathway in melanoma.
Cancer Research·2013
Combination of ACY1215, a Selective Histone Deacetylase 6 (HDAC6) Inhibitor with the Bruton Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, Represents a Novel Therapeutic Strategy in Mantle Cell Lymphoma (MCL)
Blood·2012· 8 cited
Inhibition of Histone Deacetylase 6 (HDAC6) Disrupts the Tolerogenic STAT3 Signaling Pathway and Augments Antitumor Immune Responses in Mantle Cell Lymphoma (MCL)
Blood·2012
Critical Role for Histone Deacetylase 6 (HDAC6) in the Regulation of IL-6, and the JAK/STA3 Signaling Cascade in Macrophages
Blood·2012
page 1 of 2Next →

Frequent Co-authors

Fengdong Cheng(19), Eduardo M. Sotomayor(19), Patricio Perez-Villarroel(18), Tessa Knox(15), Eva Sahakian(15), Alejandro Villagra(13), John J. Powers(12), Karrune Woan(12), Javier Pinilla‐Ibarz(12), Alejandro Villagra(10), Alan P. Kozikowski(9), Edward Seto(9), Jeffrey S. Weber(9), David Woods(9), Danay Marante(9), Hongwei Wang(8), Ed Seto(8), Susan Deng(7), Calvin Lee(7), Jorge Canales(6)